Mobility patterns of Aboriginal injection drug users between on-and off-reserve settings in northern British Columbia, Canada

References

• Public Health Agency of Canada. HIV/AIDS EPI Updates, May 2005: Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control. Ottawa: Public Health Agency of Canada; 2005. Cat. HI21–5/2005E. 128 pp.
   Google Scholar
• Craib KJ, Spittal PM, Wood E et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ 2003; 168(1): 19–24.
   Google Scholar
• Frischer M. Mobility and the diffusion of drug injecting and HIV infection. In: Stimson GV, Des Jarlais DC, Ball A, editorss. Drug injecting and HIV infection. London: UCL Press; 1998. p.101–114.
   Google Scholar
• Rhodes T, Ball A, Stimson GV et al. HIV infection associated with drug injecting in the newly independent states, Eastern Europe: the social and economic context of epidemics. Addiction 1999; 94 (9): 1323–1336.
   Google Scholar
• Steinberg S, Fleming P. The geographic distribution of AIDS in the United States: is there a rural epidemic? J Rural Health 2000;16 (1): 11–19.
   PubMed Web of Science ®Google Scholar
• Shabbir I, Larson CP. Urban to rural routes of HIV infection spread in Ethiopia. J Trop Med Hyg 1995 ; 98 (5): 338–342.
   PubMed Web of Science ®Google Scholar
• BC Ministry of Health Planning. Priorities for action in managing the epidemics: HIV/AIDS in BC: 2003–2007. Vancouver: BC Ministry of Health Services; September 2003. 53 pp.
   Google Scholar
• Public Health Agency of Canada. HIV/AIDS Epi Updates, 2003. Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control. Ottawa: Public Health Agency of Canada; April 2003. 82 pp.
   Google Scholar
• Watershed Writing and Research. Joining the circle: an Aboriginal harm reduction model. Ottawa: The Canadian Aboriginal AIDS Network; 1998. 65 pp.
   Google Scholar
• Statistics Canada. 2001 Census: analysis series; Aboriginal peoples of Canada: a demographic profile. Ottawa: Statistics Canada; January 2003. Catalogue No. 96F0030XIE2001007. 25 pp.
   Google Scholar
• Heath K, Li K, Muller J, Hogg R, O’Shaughnessy MV, Schechter MT. Honouring the warrior spirit: bringing change through protecting, preparing and providing. A collaborative report on the occurrence of Human Immunodeficiency Virus, Hepatitis C and Tuberculosis in Aboriginal injection drug users in Vancouver. Vancouver: Centre for Health Evaluation and Outcome Sciences (CHEOS); December 2001. Monograph 9.
   Google Scholar
• Spittal P, Craib KJ, Schechter MT, Medd L, Barney L, Baylis C. HIV and HCV prevalence and risk factors among young Aboriginal drug users in Vancouver and Prince George, British Columbia. Paper presented at the CAHR’s 14th Annual Canadian Conference on HIV/AIDS Research, Vancouver, BC;2005.
   Google Scholar
• Callaghan RC. Risk factors associated with dropout and readmission among First Nations individuals admitted to an inpatient alcohol and drug detoxification program. CMAJ 2003; 169 (1): 23–27.
   PubMed Web of Science ®Google Scholar
• Tukey J. Exploratory data analysis. Reading, MA: Addison-Wesley; 1977. 688 pp.
   Google Scholar
• Young H. Integrating HIV/AIDS into First Nations health services. AIDS STD Health Promot Exch 1995 (4): 3.
   Google Scholar
• Des Jarlais DC, Dehne K, Casabona J. HIV surveillance among injecting drug users. AIDS. 2001;15 (Suppl 3):S13–S22.
   Google Scholar
• Goldberg D. Methodology of the World Health Organization Multi-City Study on Drug Injecting and Risk of HIV Infection. In: Stimson GV, Des Jarlais DC, Ball AL, editors. Drug injecting and HIV infection: global dimensions and local responses. London: UCL Press; 1998. p.233–242.
   Google Scholar
• Des Jarlais DC, Perlis TE, Stimson GV, Poznyak V. Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II. BMC Public Health 2006; 6: 54.
   Web of Science ®Google Scholar